Etiologics Ltd.
http://www.mvfund.com/etiologics
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Etiologics Ltd.
GW/Bayer: Sharing Value
In its late-stage licensing deal with GW Pharmaceuticals for Sativex, Bayer accepted UK-only rights, and will share the product's value equally with GW. This unusual agreement largely reflects the particular nature of the product. But it also shows that, at least in some situations, biotechs can still partner out their jewels without giving away too much value.
Recent Dealmaking (7/2003)
Summarizing the month in European dealmaking.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice